Envoy Medical (Envoy Medical) COGS-to-Revenue : 2.59 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical COGS-to-Revenue?

Envoy Medical's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.15 Mil. Its Revenue for the three months ended in Mar. 2024 was $0.06 Mil.

Envoy Medical's COGS to Revenue for the three months ended in Mar. 2024 was 2.59.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Envoy Medical's Gross Margin % for the three months ended in Mar. 2024 was -159.32%.

Envoy Medical COGS-to-Revenue Historical Data

The historical data trend for Envoy Medical's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical COGS-to-Revenue Chart

Envoy Medical Annual Data

Trend

Dec21

Dec22

Dec23

COGS-to-Revenue

2.48

2.10

2.50

Envoy Medical Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial				2.24	5.29	2.36	2.46	2.59

Envoy Medical COGS-to-Revenue Calculation

Envoy Medical's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.789	/	0.316
	=	2.50

Envoy Medical's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.153	/	0.059
	=	2.59

Envoy Medical (NAS:COCH) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Envoy Medical's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.153 / 0.059
	=	-159.32 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Envoy Medical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Envoy Medical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Envoy Medical (Envoy Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

4875 White Bear Parkway, White Bear Lake, MN, USA, 55110

Website

https://www.envoymedical.com

Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.